BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Breast Cancer
,
Embryo
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclophosphamide
Summary
General Info
Curated Studies
Most Correlated Studies
Breast tumors with pathologic complete response (pCR) or residual disease (RD) upon chemotherapy
HepG2 cells treated with genotoxic and non-genotoxic agents
Multiple myeloma CD34+ stem cells from patients treated with bortezomib-based mobilization
CD34+ hematopoietic progenitor cells (HPCs) in multiple sclerosis patients
Diffuse large B cell lymphomas from brains of primary CNS lymphoma patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Effects of Aerobic Exercise Combined with Oyster Peptide Supplement on the Formation of CTX-induced …
Cyclodextrin Nanosponges Inclusion Compounds Associated with Gold Nanoparticles for Potential Applic…
The dark side of cyclophosphamide: cyclophosphamide-mediated ablation of regulatory T cells.
Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?
Effects of ozone therapy on cyclophosphamide-induced urinary bladder toxicity in rats.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cyclophosphamide and Alemtuzumab In Lymphoma
Cyclophosphamide for Nasopharyngeal Carcinoma
Cabozantinib With Topotecan-Cyclophosphamide
High-Dose Cyclophosphamide for Steroid Refractory GVHD
Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ